These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 3912791)

  • 21. A tale of two cultures; do we differ?
    Hoffenberg R
    Ann N Y Acad Sci; 1988; 530():16-23. PubMed ID: 3044219
    [No Abstract]   [Full Text] [Related]  

  • 22. Justice and cost-containment in end-stage renal disease.
    Johnstone BV
    J Contemp Health Law Policy; 1987; 3():65-84. PubMed ID: 10301637
    [No Abstract]   [Full Text] [Related]  

  • 23. Health policy report. Funding the End-Stage Renal-Disease Program.
    Iglehart JK
    N Engl J Med; 1982 Feb; 306(8):492-6. PubMed ID: 7035954
    [No Abstract]   [Full Text] [Related]  

  • 24. Professional integrity and global budgeting: a study of physician gatekeeping in the British National Health Service.
    Baker R
    Prof Ethics; 1993; 2(1-2):3-34. PubMed ID: 11652263
    [No Abstract]   [Full Text] [Related]  

  • 25. End stage renal disease and Medicare.
    Greer JW
    Health Care Financ Rev; 2003; 24(4):1-5. PubMed ID: 14628396
    [No Abstract]   [Full Text] [Related]  

  • 26. Ethical issues in geriatric nephrology: overview.
    Cummings NB
    Am J Kidney Dis; 1990 Oct; 16(4):367-71. PubMed ID: 2220788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All for one or one for all? The ethics of resource allocation for health care.
    Leeder SR
    Med J Aust; 1987 Jul; 147(2):68-71. PubMed ID: 3600455
    [No Abstract]   [Full Text] [Related]  

  • 28. Dialysis decision making in Canada, the United Kingdom, and the United States.
    McKenzie JK; Moss AH; Feest TG; Stocking CB; Siegler M
    Am J Kidney Dis; 1998 Jan; 31(1):12-8. PubMed ID: 9428446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The social contract and the treatment of permanent kidney failure.
    Rettig RA
    JAMA; 1996 Apr; 275(14):1123-6. PubMed ID: 8601933
    [No Abstract]   [Full Text] [Related]  

  • 30. Negative selection of patients for dialysis and transplantation in the United Kingdom.
    Challah S; Wing AJ; Bauer R; Morris RW; Schroeder SA
    Br Med J (Clin Res Ed); 1984 Apr; 288(6424):1119-22. PubMed ID: 6424755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of resources needed to achieve the national target for treatment of renal failure.
    Wood IT; Mallick NP; Wing AJ
    Br Med J (Clin Res Ed); 1987 Jun; 294(6585):1467-70. PubMed ID: 3111591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial, sexual and age inequalities in chronic dialysis.
    Kjellstrand CM; Logan GM
    Nephron; 1987; 45(4):257-63. PubMed ID: 3587465
    [No Abstract]   [Full Text] [Related]  

  • 33. Medical ethics needs a third dimension.
    McCarthy L
    J Med Ethics; 1982 Sep; 8(3):147-9. PubMed ID: 7131500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Would you deny this patient dialysis?
    Levine DZ
    Am J Kidney Dis; 1998 Jan; 31(1):131-2. PubMed ID: 9428464
    [No Abstract]   [Full Text] [Related]  

  • 35. The organization and financing of end-stage renal disease in Spain.
    Luño J
    Int J Health Care Finance Econ; 2007 Dec; 7(4):253-67. PubMed ID: 17602295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The organization and financing of dialysis and kidney transplantation services in New Zealand.
    Ashton T; Marshall MR
    Int J Health Care Finance Econ; 2007 Dec; 7(4):233-52. PubMed ID: 17638073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The organization of medical care. Lessons from the Medicare end stage renal disease program.
    Levinsky NG
    N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437
    [No Abstract]   [Full Text] [Related]  

  • 38. Purchasing services for end stage renal failure: the potential and limitations of existing information sources.
    Beech R; Mandalia S; Melia J; Mays N; Swan A
    Health Trends; 1993; 25(2):60-4. PubMed ID: 10130809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicare program: End-Stage Renal Disease program; revised network area designations--HCFA. Final rule.
    Fed Regist; 1987 Oct; 52(191):37018-25. PubMed ID: 10301901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications for health care policy. A social and demographic profile of hemodialysis patients in the United States.
    Evans RW; Blagg CR; Bryan FA
    JAMA; 1981 Feb; 245(5):487-91. PubMed ID: 6779018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.